BioSpace News Archive

Drug Development

Merck’s New Pneumococcal Vaccine Headed to Regulators by End of Year

Merck reported results from two more Phase III trials of V114, it’s 15-valent pneumococcal conjugate vaccine.

October 20, 2020
·
2 min read
·
Mark Terry
Business

Vifor Pharma and Cara Expand Licensing Deal for Late-Stage Kidney Disease Drug Korsuva

Under terms of the Korsuva deal, Connecticut-based Cara Therapeutics will receive $100 million in an upfront payment, as well as an equity investment of $50 million. Additional milestone payments could bring the total of the deal to about $290 million.

October 20, 2020
·
2 min read
·
Alex Keown
Drug Development

Biopharma Update on the Novel Coronavirus: October 20

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for October 20, 2020.

October 20, 2020
·
5 min read
·
BioSpace Editorial Staff
Policy

UK Government Plans Human COVID-19 Challenge Trials with CRO

In a challenge trial, people are given a vaccine then intentionally dosed with the virus or bacteria that causes the disease.

October 20, 2020
·
4 min read
·
Mark Terry
Drug Development

Aptinyx Jumps Following Positive Phase II PTSD Study Results

Shares of Aptinyx skyrocketed more than 75% after the company reported its mid-stage experimental treatment for post-traumatic stress disorder demonstrated clinically meaningful and statistically significant results that will set up a pivotal study next year.

October 20, 2020
·
2 min read
·
Alex Keown
Moffitt Cancer Center Sees Breakthrough in Latest Pan-Cancer Analysis

Through their work, they were able to determine that the protein, TAp63, appears to impact the level of RNA molecules within the body. This subsequently connects the activities of p53 and AKT, the altered genes in cancer.

October 20, 2020
·
3 min read
·
Krystle Vermes
Job Trends

INCOG BioPharma Paves the Way for New Jobs with Expansion in Indiana

INCOG BioPharma Services, is a biopharmaceutical manufacturing services startup that will be establishing a manufacturing plant soon. You can get more details here.

October 20, 2020
·
3 min read
·
Krystle Vermes
Job Trends

How Kite is Building its CAR-T Franchise Despite COVID-19 Restrictions

Kite, a Gilead company, is building a franchise, not just a brand, on the promise of its CAR-T cell therapies.

October 20, 2020
·
5 min read
·
Gail Dutton
Lone Star Bio

MD Anderson Brings Underdogs into the Fight Against Cancer with Focus Fund

With an initial capital of $50 million, MD Anderson and partner The Focus Fund hope to invest in small biotechs with big cancer-fighting potential.

October 20, 2020
·
3 min read
·
Kate Goodwin
Surgical Drapes Market: Disposable Surgical Drapes To Dominate Market In Term Of Usability

Transparency Market Research has published a new report titled, Surgical Drapes Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

October 20, 2020
·
5 min read